Oue Lippo Healthcare Ltd
SGX:5WA
Intrinsic Value
OUE Lippo Healthcare Ltd. is as an investment holding company, which engages in the provision of healthcare services and facilities. [ Read More ]
The intrinsic value of one 5WA stock under the Base Case scenario is 0.14 SGD. Compared to the current market price of 0.027 SGD, Oue Lippo Healthcare Ltd is Undervalued by 81%.
Valuation Backtest
Oue Lippo Healthcare Ltd
Run backtest to discover the historical profit from buying and selling 5WA stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Oue Lippo Healthcare Ltd
| Current Assets | 83.9m |
| Cash & Short-Term Investments | 59.6m |
| Receivables | 22.8m |
| Other Current Assets | 1.4m |
| Non-Current Assets | 1.4B |
| Long-Term Investments | 1.3B |
| PP&E | 8.8m |
| Intangibles | 30.7m |
| Other Non-Current Assets | 3.2m |
| Current Liabilities | 103.3m |
| Accounts Payable | 46.5m |
| Other Current Liabilities | 56.8m |
| Non-Current Liabilities | 1.1B |
| Long-Term Debt | 519.5m |
| Other Non-Current Liabilities | 531.1m |
Earnings Waterfall
Oue Lippo Healthcare Ltd
|
Revenue
|
159.3m
SGD
|
|
Cost of Revenue
|
-37.6m
SGD
|
|
Gross Profit
|
121.7m
SGD
|
|
Operating Expenses
|
-29.1m
SGD
|
|
Operating Income
|
92.6m
SGD
|
|
Other Expenses
|
-84.6m
SGD
|
|
Net Income
|
8m
SGD
|
Free Cash Flow Analysis
Oue Lippo Healthcare Ltd
5WA Profitability Score
Profitability Due Diligence
Oue Lippo Healthcare Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Oue Lippo Healthcare Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
5WA Solvency Score
Solvency Due Diligence
Oue Lippo Healthcare Ltd's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Score
Oue Lippo Healthcare Ltd's solvency score is 25/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
5WA Price Targets Summary
Oue Lippo Healthcare Ltd
Shareholder Return
5WA Price
Oue Lippo Healthcare Ltd
| Average Annual Return | -16.09% |
| Standard Deviation of Annual Returns | 24.26% |
| Max Drawdown | -66% |
| Market Capitalization | 120m SGD |
| Shares Outstanding | 4 443 129 206 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
OUE Lippo Healthcare Ltd. is as an investment holding company, which engages in the provision of healthcare services and facilities. The firm owns, operates and invests in healthcare businesses Asian markets. The Company’s segments include Healthcare operations, Healthcare assets, Properties under development and Investments. The Healthcare Operations segment includes the operation of hospitals and trading of pharmaceutical supplies and drugs and has operations in China and Myanmar. The Properties under development segment includes development of medical facilities, healthcare-related assets and integrated mixed-used projects and has development properties in China and Malaysia. The Healthcare assets segment includes rental of investment properties and assets owned by the Company and has assets in Japan and China. The Investments segment has investments in real estate investment trust (REIT) and REIT manager. OUELH also holds a 50% equity interest in China Merchants Lippo Hospital Management (Shenzhen) Limited (CM Lippo).
Officers
The intrinsic value of one 5WA stock under the Base Case scenario is 0.14 SGD.
Compared to the current market price of 0.027 SGD, Oue Lippo Healthcare Ltd is Undervalued by 81%.
You don't have any saved screeners yet
